Related references
Note: Only part of the references are listed.Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model
Amer N. Kalaaji et al.
CYTOKINE (2010)
Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma
Anne-Marie Mohty et al.
IMMUNOBIOLOGY (2010)
Biomarkers: The Useful and the Not So Useful- An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma
Bonnie E. Gould Rothberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
Simone Mocellin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Utility of adjuvant systemic therapy in melanoma
A. M. M. Eggermont et al.
ANNALS OF ONCOLOGY (2009)
Clinical and Immunologic Basis of Interferon Therapy in Melanoma
Ahmad A. Tarhini et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
The lymphotoxin-β receptor is an upstream activator of NF-κB-mediated transcription in melanoma cells
Punita Dhawan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Failure at the effector phase: Immune barriers at the level of the melanoma tumor microenvironment
Thomas F. Gajewski
CLINICAL CANCER RESEARCH (2007)
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
C. Monteagudo et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Multiplex analysis of serum cytokines in melanoma patients treated with interferon-α2b
Zoya R. Yurkovetsky et al.
CLINICAL CANCER RESEARCH (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Elastin fragments induce IL-1β upregulation via NF-κB pathway in melanoma cells
Romain Debret et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells
ED Feldman et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH cytokine production
P Romagnani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Melanoma skews dendritic cells to facilitate a T helper 2 profile
M McCarter et al.
SURGERY (2005)
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor
AA Lugade et al.
JOURNAL OF IMMUNOLOGY (2005)
Stromal responses in human primary melanoma of the skin
LCL van Kempen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Dysfunctional blood and target tissue CD4(+)CD25(high) regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation
H Sugiyama et al.
JOURNAL OF IMMUNOLOGY (2005)
Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-κB-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli
PA Henriksen et al.
JOURNAL OF IMMUNOLOGY (2004)
In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model
S Pasco et al.
EXPERIMENTAL CELL RESEARCH (2004)
Cytokines in cancer immunity and immunotherapy
MJ Smyth et al.
IMMUNOLOGICAL REVIEWS (2004)
The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan
JM Yang et al.
MOLECULAR THERAPY (2004)
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease
IM Mullins et al.
CANCER RESEARCH (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines
G Opdenakker et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Annexin AI processing is associated with caspase-dependent apoptosis in BZR cells
R Debret et al.
FEBS LETTERS (2003)
Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells
J Fleischer et al.
JOURNAL OF IMMUNOLOGY (2002)
The role of chemokines in melanoma tumor growth and metastasis
AS Payne et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts
AL Feldman et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death
M Mellado et al.
CURRENT BIOLOGY (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Expression of the Th1 chemokine IFN-γ-inducible protein 10 in the airway alters mucosal allergic sensitization in mice
RE Wiley et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
